A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in XenograftsKoshi Kawakami, Yoshio Honma, Takatsugu Inoue et al.|Anti-Cancer Agents in Medicinal Chemistry|2012Cited by 36